Pan Pantziarka
Meise, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Reply to 'Stimulating medicines repurposing in the EU: a pilot project'.
Journal: Nature reviews. Drug discovery
Published: June 08, 2026
Sulfonylureas beyond diabetes: A comprehensive review on anticancer and off-target effects (1956-2025).
Journal: European journal of medicinal chemistry
Published: April 12, 2026
Paediatric therapeutic development workshop on osteosarcoma.
Journal: British journal of cancer
Published: April 07, 2026
Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challenges.
Journal: Health policy OPEN
Published: November 24, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.
Journal: JCO precision oncology
Published: September 19, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Journal: Cancer treatment reviews
Published: June 13, 2025
Approaches to Ultra-Rare Sarcomas: Definitions, Diagnostics, and Therapies.
Journal: Hematology/oncology clinics of North America
Published: May 14, 2025
The eyes of the beholder: Perceived barriers to successful drug repurposing.
Journal: British journal of pharmacology
Published: February 11, 2025
Synergistic Potential of Antibiotics with Cancer Treatments.
Journal: Cancers
Published: November 20, 2024
Genetic predisposition in sarcomas: clinical implications and management.
Journal: EClinicalMedicine
Published: October 12, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2024
Last Updated: 09/26/2026